PAST EVENT
From 1975 until 1982, Doblin owned and operated a company called Braxas Construction, located in the Sarasota, Florida area, which specialized in relocating houses. He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master’s thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. He currently resides in Boston with his wife and three children and two dogs.
Doblin obtained a psychology degree from New College of Florida in 1987 and earned a doctorate in public policy from the Kennedy School of Government, Harvard University in 2001. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary’s Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner.
He co-founded Earth Metabolic Design Laboratories in 1984 to support psychedelic research and Multidisciplinary Association for Psychedelic Studies (MAPS) in 1986 with the goal of making MDMA an FDA-approved medicine.
Rick Doblin’s life is profiled in former Washington Post Magazine editor Tom Shroder’s book Acid Test: LSD, Ecstasy, and the Power to Heal.
Psychedelic Psychotherapy Forum 2016 from Stream of Consciousness on Vimeo.
This Forum engages psychotherapists, psychologists, physicians, psychiatrists, body workers, and anyone interested in the healing potential of psychedelic medicine. Our keynote speaker this year is Dr. Robin Carhart-Harris, who will be joined by Dr. Joe Tafur, Rachel Harris, PhD, Leanna Standish, PhD, Dr. Donna Dryer, Richard Yensen, PhD, Kenneth Tupper, PhD, and more…
Julia Allen, MCP, RCC; Panel: “A New Medical Model: Holistic Medicine and Psychedelic Psychotherapy”
Meaghan Buisson, 47-time Canadian national champion and current world record holder in the sport of inline speed skating; one of six Canadian participants in the Phase II clinical trial for MDMA-assisted psychotherapy for treatment-resistant PTSD. Presentation: “MDMA-Assisted Psychotherapy: A Personal Journey”
Devon Christie, MD; Certified Functional Medicine Practitioner, with the US-based Institute for Functional Medicine (IFM). Presentation: “An Invitation to Wholeness: Psychedelic & the Future of Medicine;” Panels: “A New Medical Model: Holistic Medicine and Psychedelic Psychotherapy;” “Tying Your Shoes in Hyperspace: Integrating the Psychedelic Experience.”
Sasha Cuff, RTC(c) Panels: “A New Medical Model: Holistic Medicine and Psychedelic Psychotherapy;” “Tying Your Shoes in Hyperspace: Integrating the Psychedelic Experience.”
Rick Doblin, Ph.D., founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). Keynote address: “Mainstreaming Psychedelics: Six Decades of Cultural Evolution from 1966 to 2026” Panel: “MDMA: The Promise and Challenge for New Paradigm of Healing”
Donna Dryer, MD, FRCPC, is a transpersonal psychiatrist in private practice on the coast islands of British Columbia; assisted with MAPS sponsored research study of MDMA for people with treatment- resistant Post Traumatic Stress Disorder in Vancouver. Panels: “MDMA: The Promise and Challenge for New Paradigm of Healing;” “Harvard or Hogwarts? – Training the Psychedelic Psychotherapists”
Frank Echenhofer, PhD; Panels: “The Mystical Experience in Psychedelic Work;” “Tying Your Shoes in Hyperspace: Integrating the Psychedelic Experience.”
Yalila Espinoza, PhD, integrative health advisor; Panel: “Tying Your Shoes in Hyperspace: Integrating the Psychedelic Experience.”
Carolyn Green, PhD, certified Grof facilitator; Panel: “Holotropic (TM) Breathwork”
Mark Haden, MSW; Chair, MAPS Canada; Adjunct Professor at the University of British Columbia School of Population and Public Health; Presentation: “A Post-Prohibition Model for the Regulation of Psychedelics”
James Jesso, author of Decomposing The Shadow and The True Light Of Darkness; Presentation: “Potential Mechanisms Behind the Treatment of Chronic Depression with Psilocybin“
Adèle Lafrance, PhD, C. Psych; Psychologist and Associate Professor at Laurentian University in Sudbury, Ontario; Presentation: “Feeding the Soul with Ayahuasca-assisted Therapy: A Promising Treatment of the Healing of Eating Disorders;” “The Mystical Experience in Psychedelic Work“
Philippe Lucas, Vice President of Patient Advocacy at Tilray, a federally authorized medical cannabis production, research and distribution company based in Nanaimo, BC; Presentation: “Medical Cannabis & Mental Health Research Under the MMPR”
Sarah Mattson; Presentation: “A Post-Prohibition Model for the Regulation of Psychedelics”
Trevor Millar, owner of Liberty Root Therapy; Presentation: “Psychedelic Entrepreneurship”
Marcela Ot’alora, MA, LPC, co-therapist in the first government approved MDMA-assisted psychotherapy study in Madrid Spain; Principal Investigator of the Phase II MDMA-assisted psychotherapy study in Boulder, Colorado. Presentation: “Relieving Symptoms of PTSD with MDMA;” Panel: “MDMA: The Promise and Challenge for New Paradigm of Healing”
Ingrid Pacey, MD, psychiatrist; lead investigator of MDMA/PTSD study to Vancouver completed in 2017. Panels: “MDMA: The Promise and Challenge for New Paradigm of Healing;” “Holotropic (TM) Breathwork”
Dawn Rabey, PhD, CCC, RCC; transpersonal psychotherapist in Victoria, BC. Panel: “Tying Your Shoes in Hyperspace: Integrating the Psychedelic Experience.”
William A. (Bill) Richards, PhD; psychologist in the Psychiatry Department of the Johns Hopkins University School of Medicine, where he and his colleagues have pursued psychedelic research during the past 16 years. Presentation: “Psilocybin Studies and Implications for Cancer Patients and End of Life Issues;” Panel: “The Mystical Experience in Psychedelic Work”
Hayden Rubensohn, MD; Panel: “MDMA: The Promise and Challenge for New Paradigm of Healing”
Bruce Tobin, PhD, RCC; Panel: “The Road Forward to Legal Psychedelic Psychotherapy: the Moving Forward Project;” “Holotropic (TM) Breathwork”
Zach Walsh, PhD; Presentation: “Psychedelic Therapy and Third-wave Behaviorism: New Directions for the Prevention of Interpersonal Violence”
Richard Yensen, PhD; co-principal investigator for the MAPS sponsored PTSD & MDMA phase 2 psychotherapy study completed in 2017 in Vancouver. Panels: “MDMA: The Promise and Challenge for New Paradigm of Healing;” “Harvard or Hogwarts? – Training the Psychedelic Psychotherapists“